EMILY PAGE: Open Payments
NPI 1477274264 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 29 payments from 11 companies in 2025. Trend: 2023 $365 · 2024 $640 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $183 |
| AKEBIA THERAPEUTICS INC | 4 | $168 |
| Apellis Pharmaceuticals, Inc. | 1 | $113 |
| Novartis Pharmaceuticals Corporation | 6 | $111 |
| NxStage Medical, Inc. | 1 | $89 |
| Calliditas Therapeutics US Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Travere Therapeutics, Inc. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $17 |
Products named: KRYSTEXXA, Fabhalta, Vafseo, LIBERTY SELECT CYCLER, Auryxia, TARPEYO, TAVNEOS, JARDIANCE.
Industry payments across NC — which companies pay providers there.
